Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

Description

The effects of the medication, memantine, on brain functions and the symptoms of Alzheimer's Disease will be tested

Conditions

Alzheimer Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The effects of the medication, memantine, on brain functions and the symptoms of Alzheimer's Disease will be tested

Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

Condition
Alzheimer Disease
Intervention / Treatment

-

Contacts and Locations

San Diego

Clinical Teaching Facility (CTF-B102) at UCSD Medical Center, San Diego, California, United States, 92103

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    50 Years to 83 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    University of California, San Diego,

    Neal Swerdlow, M.D., Ph.D., PRINCIPAL_INVESTIGATOR, UCSD

    Study Record Dates

    2025-05-31